Ideal candidates are usually adults dealing with obesity or related health conditions, such as type 2 diabetes or high cholesterol, who have struggled to achieve significant weight loss through traditional methods
Ipamorelin, CJC-1295, BPC-157, TB-500, GHK-Cu, and KPV remain in the preclinical stage
This is why patients often experience worsening symptoms over time, even when they cannot detect mold in their environment
To date, major clinical trials have only tested GLP1 agonists in the form theyre FDA-approved for primarily as once-weekly injections
However, its precise regulatory mechanisms remain largely elusive (142)
A slower, more individualised titration approach can reduce the severity and duration of adverse effects